Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    Pacific Bio releases some details on SMRT Sequencer read lengths, library prep

    Our friends over at In Sequence posted a very interesting article containing details from Pacific Biosciences regarding their much anticipated third-gen uber-sequencer.

    I certainly don't want to steal their scoop so I won't go into detail here...I encourage you to visit their site as it's the first detailed look at what PB may offer as soon as 2010.

    Some points include long (Sanger-sized) or short reads, and five minute run times!

    UPDATED: In Sequence open access article here and above. Thanks to the editors at In Sequence for creating the open access link and for permission to repost.
  • bioinfosm
    Senior Member
    • Jan 2008
    • 483

    #2
    In sequence subscription is the issue
    --
    bioinfosm

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      I know. I'm not sure I feel right about posting info that is their site's core value.

      Plus they are very nice people. Perhaps I'll write a summary later today.

      EDIT: Just updated the first post with an open-access link to the article. Thanks to the editors of In Sequence for creating the link and permission to post.

      Comment

      • bioinfosm
        Senior Member
        • Jan 2008
        • 483

        #4
        good job Eco!

        Other articles possible as well *greedy me*
        --
        bioinfosm

        Comment

        • apfejes
          Senior Member
          • Feb 2008
          • 236

          #5
          I spent half the morning running around trying to find someone with a subscription... Thanks to In Sequence for allowing this article to be released as open access, and thanks for posting the link, ECO!
          The more you know, the more you know you don't know. —Aristotle

          Comment

          • ECO
            --Site Admin--
            • Oct 2007
            • 1360

            #6
            Originally posted by bioinfosm View Post
            good job Eco!

            Other articles possible as well *greedy me*
            Originally posted by apfejes View Post
            I spent half the morning running around trying to find someone with a subscription... Thanks to In Sequence for allowing this article to be released as open access, and thanks for posting the link, ECO!
            Believe it or not, In Sequence is open access to education users. The editor told me the process is currently a bit clunky and they are working on that, but it's definitely possible now.

            Comment

            • apfejes
              Senior Member
              • Feb 2008
              • 236

              #7
              Heh... I guess I should have spent more time trying to navigate their site than to find someone who already had access. Old habits die hard, I suppose.

              One more publication to add to the reading list, then!
              The more you know, the more you know you don't know. —Aristotle

              Comment

              Latest Articles

              Collapse

              • SEQadmin2
                Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                by SEQadmin2



                Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                ...
                Yesterday, 11:10 AM
              • SEQadmin2
                Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                by SEQadmin2



                Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                07-08-2026, 05:17 AM
              • GATTACAT
                Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
                by GATTACAT
                Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
                07-01-2026, 11:43 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by SEQadmin2, Yesterday, 10:04 AM
              0 responses
              10 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-08-2026, 10:08 AM
              0 responses
              7 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-07-2026, 11:05 AM
              0 responses
              14 views
              0 reactions
              Last Post SEQadmin2  
              Started by SEQadmin2, 07-02-2026, 11:08 AM
              0 responses
              31 views
              0 reactions
              Last Post SEQadmin2  
              Working...